VBWG

VBWG QuickTake

Bert Pitt MRAs

The Advent of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure Bertram Pitt, MD

SPRINT Trial

Results of the Systolic Blood Pressure Intervention Trial (SPRINT) Paul Whelton, MB, MD, MSc

Darren McGuire

Antidiabetic Therapy Reduces Mortality and Heart Failure in High-Risk Patients Darren McGuire, MD, MHSc

SOCRATES Trial

Vericiguat in Patients with Worsening Heart Failure: Results of SOCRATES-REDUCED Trial Javed Butler, MD, MPH

Slides

Core Curriculum

Progress and Promise in RAAS Blockade

View/Download individual slides (82 Slides)

Core Curriculum

Leading the Way in Cardiovascular Regenerative Medicine

View/Download individual slides (54 Slides)

Core Curriculum

Vascular Dysfunction: Sequelae of Acute Hypertension

View/Download individual slides (84 Slides)

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

Core Curriculum

Hyperglycemia and Acute Coronary Syndromes

View/Download individual slides (84 Slides)

Core Curriculum

Contemporary Management of Cardiometabolic Risk

View/Download individual slides (105 Slides)

Core Curriculum

Advancing Our Understanding of RAAS Modulation in High-Risk Patients

View/Download individual slides (67 Slides)

ADOPT: A Diabetes Outcome Progression Trial

View/Download individual slides (15 Slides)
More slides >

E-Learning

Using TAVR in Lower and Lower Risk Patients.

Ron Waksman, MD
Washington Hospital Center
Washington, DC

Lipids 2016: Update on the Metamorphosis Occurring in Lipid Therapy Today.

Robert P. Giugliano, MD
TIMI Study Group
Boston, MA  

Benefits and Limitations of Antiplatelet Therapy. How Can We Advance the Field?

Paul A. Gurbel, MD
Johns Hopkins University School of Medicine
Baltimore, MD 

Current and Future Perspectives in the Treatment of Pulmonary Hypertension.

Paul R. Forfia, MD
Temple University School of Medicine
Philadelphia, PA

Integrating Big Data with Evidence Generation for Precision Medicine: Implications for Cardiovascular Disease.

Elliott M. Antman, MD, MACC
Immediate Past President AHA
Harvard Medical School
Boston, MA

Treating HTN Today: Insights from SPRINT and the New Clinical Practice Guidelines for Patients with CAD.

Clive Rosendorff, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY

Cardiovascular Outcomes with Medicines to Control Glycemia: Highlights from Recently Completed Trials.

Darren K. McGuire, MD, MHSc
UT Southwestern Medical Center
Dallas, TX

Where Are We With Systolic Heart Failure?

Ileana Pina, MD, MPH
Montefiore Medical Center
Bronx, NY

Are We Back to Lower is Better: Time to Revise the 2014 Guidelines?

Stephen D. Wiviott,  MD
Brigham and Women’s Hospital
Boston, MA 

New Directions in Antiplatelet Therapy

David A. Morrow, MD, MPH
Brigham and Women’s Hospital
Boston, MA
More e-learning >

Continuing Education

The VBWG Twentieth Anniversary

Dr Carl J. Pepine reports on the achievements of the Vascular Biology Working Group at the National Faculty Meeting, Washington, DC. The Vascular Biology Working Group celebrated its twentieth anniversary at its meeting just preceding the American College of Cardiology Annual Scientific Sessions (ACC14) in Washington, DC, on 28 March 2014

Self Study





PREVIOUS CONFERENCES

VBWG US Chapter Meeting
April 1, 2016
Chicago, IL
AGENDA
View presentations under E-LEARNING


VBWG Global Chapter Meeting At AHA
November 7, 2015
Orlando, FL
AGENDA
View presentations under E-LEARNING

VBWG US Chapter Meeting
March 13, 2015
San Diego, CA
AGENDA
View presentations under E-LEARNING


VBWG Global Chapter Meeting
November 15, 2014
Chicago, IL
AGENDA
View presentations under E-LEARNING

VBWG US Chapter Meeting
March 28, 2014
Washington, DC
AGENDA
View presentations under E-LEARNING

VBWG Global Chapter Meeting
November 16, 2013
Dallas, TX
AGENDA
View presentations under E-LEARNING

 
More education >

Monograph

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More monographs >